Friday, July 17, 2026

Visa of Chinese scientist who edited babies’ genes revoked

Despite criticism from many international health experts, Mr Jiankui maintained that his scientific research and experiments were to help the poor.

• February 23, 2023
He Jiankui
He Jiankui [Photo Credit; MIT Technology Review]

Hong Kong has revoked the visa of He Jiankui, a controversial Chinese scientist who edited the gene of babies.

The Chinese scientist’s visa was revoked for giving false information, the Hong Kong authorities said on Tuesday.

Immigration officials in Hong Kong believed that Mr Jiankui, who sparked international controversy and ethical debate in 2018 after creating the world’s first “gene-edited” babies resistant to HIV, had lied on the application form for a talent scheme.

Nearly five years ago, at an international conference in Hong Kong, Mr Jiankui announced that he had achieved a scientific breakthrough by modifying two embryos before they were placed in their mother’s womb, using a technology known as CRISPR-Cas9.

Hong Kong revoked Jiankui’s work visa and launched an investigation after the public condemned the government in the wake of the news that the convicted scientist was granted one, despite having a criminal record in China for medical malpractice.

“After reviewing the application, the Immigration Department suspected the visa/entry permit was obtained by false representation, and the Director of Immigration had declared the visa/entry permits invalid in accordance with the law, and would conduct a criminal investigation to follow up,” said the Hong Kong government.

In December 2019, a court in Shenzhen, China, sentenced Mr Jiankui to three years’ imprisonment and a fine of £360,320 for breaking China’s regulations by carrying out scientific research and practising medicine without a licence after it was suspended a year earlier.

Despite criticism from many international health experts, Mr Jiankui maintained that his scientific research and experiments were to help the poor.

He opened a laboratory in Beijing solely for developing affordable drugs for rare genetic diseases.

We have recently deactivated our website's comment provider in favour of other channels of distribution and commentary. We encourage you to join the conversation on our stories via our Facebook, Twitter and other social media pages.

More from Peoples Gazette

farmers

Agriculture

FG tasks ECOWAS on leveraging financing strategies for agroecology

The federal government has urged stakeholders in the agriculture and finance sectors in the West Africa region to leverage financing strategies to enhance agroecology practices

Katsina State

Politics

Katsina youths pledge to deliver over 2 million votes to Atiku

“Katsina State is Atiku’s political base because it is his second home.”

Taraba college of education

Education

Taraba college of education to commence degree programmes

The provost assured parents of uninterrupted academic activities.

Vice-President Kashim Shettima

Heading 3

Nutrition 774: Shettima urges LG chairmen to tackle malnutrition 

He described local government chairmen as the closest tier of government to the people. 

Centre for Democracy and Development

NationWide

CDD tasks Nigerian leaders on community development

Ugwe Benedict, one of the school administrators, said the project would bring relief to the school.

World Customs Organisation

NationWide

Nigeria, Benin bust smugglers in first intelligence-led border operation

According to the organisation, the operation followed a rigorous training programme.

Children

NationWide

Investing in children strengthens Nigeria’s future: UNICEF

Ms Russell noted that Nigeria’s public health challenges could be overcome through strong leadership.

Economic Commission for Africa

Africa

ECA seeks skills harmonisation to boost youth employment in Africa

The event focused on transforming informal work into sustainable livelihoods for young people.